Ingevity Corporation has reported its first-quarter 2026 results, showing modest revenue growth, stable profitability metrics, and continued capital returns to shareholders. 

 

This was even as operating headwinds and divestitures reshaped segment performance.

 

Net sales rose 4% to $258.0 million, powered primarily by annual pricing actions across Performance Materials and Pavement Technologies, along with favorable foreign exchange movements. 

 

Despite the top-line gain, the company posted net income from continuing operations of $23.4 million and diluted EPS of $0.65, which included $22.7 million in pre-tax special charges, including a $16.2 million BASF legal settlement reimbursement tied to final litigation resolution.

 

Adjusted EBITDA held steady year-over-year at $91.5 million, as pricing strength and higher volumes were offset by weaker performance in Performance Chemicals’ Road Markings business and lower utilization in Advanced Polymer Technologies. Adjusted EBITDA margin came in at 35.5%, down from 36.8% a year earlier.

 

Adjusted earnings rose to $41.4 million, with EPS improving to $1.15, up from $37.0 million and $1.01 in the prior-year quarter.

 

“I am proud of our team’s strong execution in the face of macroeconomic volatility and rising energy costs. Closing both the Industrial Specialties and Road Markings divestitures early in the year was a significant achievement and enabled us to deploy $52 million in share repurchases ahead of our original plan. 

 

"We are maintaining our full-year outlook and are encouraged by early trends and momentum at the start of the year,” said Ingevity President and CEO, Dave Li.

 

 

Performance Materials remained the standout, with sales rising 6% to $155.4 million, driven by pricing actions, improved product mix, and higher volumes. Segment EBITDA increased 10% to $92.0 million, with margins expanding to 59.2% from 56.9% a year ago. Gains were supported by higher plant utilization and inventory builds ahead of planned outages.

 

Performance Chemicals delivered flat sales of $58.3 million, masking diverging trends. While Pavement Technologies held steady, Road Markings sales fell 10% amid competitive pressure and weaker volumes. Segment EBITDA dropped sharply to $0.6 million, down $5.2 million year-over-year, with margins compressing to 1.0% from 9.8%.

 

Advanced Polymer Technologies posted a 5% sales increase to $44.3 million, helped by foreign exchange and volume growth. However, profitability declined significantly, with EBITDA falling to $7.6 million from $13.6 million, reflecting prior-year inventory timing benefits tied to a planned outage. Margins dropped to 17.2% from 32.2%.

 

Operating cash flow came in at negative $2.0 million, down $27.4 million year-over-year, reflecting seasonal patterns and inventory builds ahead of planned outages. Free cash flow was negative $12.3 million, also affected by prior-year working capital benefits that did not repeat.

 

Despite this, Ingevity continued aggressive shareholder returns, repurchasing $52 million in stock during the quarter. Net leverage remained stable at 2.6x, improved from 3.3x a year earlier.

 

The company reaffirmed its full-year 2026 outlook, now adjusted for recent divestitures, including Road Markings. 

 

Ingevity expects: Net sales: $1.05 billion – $1.15 billion; Adjusted EBITDA: $370 million – $395 million; Adjusted EPS: $4.70 – $5.20; Free cash flow: $215 million – $245 million (excluding $113.2 million BASF settlement payment)

 

Management said cash generation will support both deleveraging toward its long-term target range of 2.0x–2.5x and continued shareholder returns through 2026.